Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

London: GSK plc has received approval from the US Food and Drug Administration (FDA) for a prefilled syringe presentation of ...

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

Some immunizations may be quietly protecting us from cognitive decline. How the medicine might do that is a mystery scientists are desperate to solve. A new study on two vaccines for older adults ...

Shingrix is also better than Zostavax in preventing nerve pain that continues after a shingles rash has cleared -- about 90 percent effective versus 65 percent effective, the briefing stated.